Clinical trial

A Study of Pertuzumab in Participants With Metastatic Breast Cancer

NCT02491892

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Pertuzumab Normalized identity: pertuzumabView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Pertuzumab in Participants With Metastatic Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-02-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

PertuzumabDRUG · verified · RxNorm: pertuzumab

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

BarcelonaSpain2 LondonUnited Kingdom1 MilanItaly1 HamburgGermany1 ValenciaSpain1 ManchesterUnited Kingdom1 AmsterdamNetherlands1 MünchenGermany1 HelsinkiFinland1 EdinburghUnited Kingdom1 TampereFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02491892 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.